Clinical Trial Update: Phase I Study of Colistin Methanesulfonate Sodium [Phase 1]

View source ↗

Summary

Phase I trial of Colistin methanesulfonate sodium for Pseudomonas infections has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pseudomonas Infections

Drugs mentioned

• Colistin methanesulfonate sodium (Colistin methanesulfonate)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Pseudomonas | Phase 1 | Status: COMPLETED